PhD Scholarship: Development and validation of novel biomarkers for musculoskeletal health

Responsibilities

• Focus on the development and validation of novel biomarkers for musculoskeletal health
• Utilize non-invasive detection methods and point-of-use biosensors
• Work at the intersection of translational medicine, proteomics, and molecular biology
• Collaborate with the Australian Shoulder Research Institute (ASRI) and clinical research teams
• Conduct extensive protein and RNA assay work

Requirements

• Bachelor degree with First Class Honours or a Master's degree (AQF Level 9) with a significant research component
• Strong academic background in Medical Laboratory Science, Pathology, Molecular Pathology, or a related field
• Demonstrated research experience working with hospital laboratories or end users
• Technical proficiency or strong interest in running protein and RNA assays
• Valid Australian Driver's license
• English language proficiency (IELTS 6.5 minimum with no band less than 6.0, or equivalent TOEFL scores)
• Strong collaborative skills and a passion for precision health research

Preferred Qualifications

• Experience in multivariate statistical analysis

Benefits

• Annual stipend of $35,656 (indexed) for up to three years of full-time study
• International applicants may receive a Griffith University International Postgraduate Research Scholarship to cover tuition fees
• Access to a world-class research environment at the Institute for Biomedicine and Glycomics (IBG)
• Professional and personal development support for all HDR candidates

About the Company

Griffith University is a leading research institution ranked among the top 2% worldwide. The Saliva and Liquid Biopsy Group, part of the ARC Research Hub for Molecular Biosensors at Point-of-Use (MOBIUS), is dedicated to advancing biomarker discovery for metabolic diseases and cancer to improve precision health.